González Gil, LorenaKrah, DanielGhattas, Ann-KathrinCarballa Arcos, MartaWick, ArneHelmholz, LissaLema Rodicio, Juan ManuelTernes, Thomas A.2019-03-042021-01-112019-04-01Gonzalez-Gil, L., Krah, D., Ghattas, A., Carballa, M., Wick, A., & Helmholz, L. et al. (2019). Biotransformation of organic micropollutants by anaerobic sludge enzymes. Water Research, 152, 202-214. doi: 10.1016/j.watres.2018.12.0640043-1354http://hdl.handle.net/10347/18325This is the accepted manuscript of the following article: Gonzalez-Gil, L., Krah, D., Ghattas, A., Carballa, M., Wick, A., & Helmholz, L. et al. (2019). Biotransformation of organic micropollutants by anaerobic sludge enzymes. Water Research, 152, 202-214. doi: 10.1016/j.watres.2018.12.064Biotransformation of organic micropollutants (OMPs) in wastewater treatment plants ultimately depends on the enzymatic activities developed in each biological process. However, few research efforts have been made to clarify and identify the role of enzymes on the removal of OMPs, which is an essential knowledge to determine the biotransformation potential of treatment technologies. Therefore, the purpose of the present study was to investigate the enzymatic transformation of 35 OMPs under anaerobic conditions, which have been even less studied than aerobic systems. Initially, 13 OMPs were identified to be significantly biotransformed (>20%) by anaerobic sludge obtained from a full-scale anaerobic digester, predestining them as potential targets of anaerobic enzymes. Native enzymes were extracted from this anaerobic sludge to perform transformation assays with the OMPs. In addition, the effect of detergents to recover membrane enzymes, as well as the effects of cofactors and inhibitors to promote and suppress specific enzymatic activities were evaluated. In total, it was possible to recover enzymatic activities towards 10 out of these 13 target OMPs (acetyl-sulfamethoxazole and its transformation product sulfamethoxazole, acetaminophen, atenolol, clarithromycin, citalopram, climbazole, erythromycin, and terbutryn, venlafaxine) as well as towards 8 non-target OMPs (diclofenac, iopamidol, acyclovir, acesulfame, and 4 different hydroxylated metabolites of carbamazepine). Some enzymatic activities likely involved in the anaerobic biotransformation of these OMPs were identified. Thereby, this study is a starting point to unravel the still enigmatic biotransformation of OMPs in wastewater treatment systemseng© 2019 Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/http://creativecommons.org/licenses/by-nc-nd/4.0/Anaerobic digestionDegradationEnzymatic transformationEnzymatic pathwaysPharmaceuticalsSewage treatment plantjournal article10.1016/j.watres.2018.12.064open access